Cargando…
Theileria equi isolates vary in susceptibility to imidocarb dipropionate but demonstrate uniform in vitro susceptibility to a bumped kinase inhibitor
BACKGROUND: The apicomplexan hemoparasite Theileria equi is a causative agent of equine piroplasmosis, eradicated from the United States in 1988. However, recent outbreaks have sparked renewed interest in treatment options for infected horses. Imidocarb dipropionate is the current drug of choice, ho...
Autores principales: | Hines, Siddra A, Ramsay, Joshua D, Kappmeyer, Lowell S, Lau, Audrey OT, Ojo, Kayode K, Van Voorhis, Wesley C, Knowles, Donald P, Mealey, Robert H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4311422/ https://www.ncbi.nlm.nih.gov/pubmed/25600252 http://dx.doi.org/10.1186/s13071-014-0611-6 |
Ejemplares similares
-
Imidocarb Dipropionate Lacks Efficacy against Theileria haneyi and Fails to Consistently Clear Theileria equi in Horses Co-Infected with T. haneyi
por: Sears, Kelly, et al.
Publicado: (2020) -
Comparative genomic analysis and phylogenetic position of Theileria equi
por: Kappmeyer, Lowell S, et al.
Publicado: (2012) -
Re-Emergence of the Apicomplexan Theileria equi in the United States: Elimination of Persistent Infection and Transmission Risk
por: Ueti, Massaro W., et al.
Publicado: (2012) -
Efficacy of oral Cynara scolymus and Silybum marianum on toxicity of imidocarb dipropionate in horses
por: Jaramillo, Fernando Mosquera, et al.
Publicado: (2020) -
Lymphocytes and Macrophages Are Infected by Theileria equi, but T Cells and B Cells Are Not Required to Establish Infection In Vivo
por: Ramsay, Joshua D., et al.
Publicado: (2013)